Early and accurate identification of brain tumors is essential for determining effective treatment strategies and improving patient outcomes. Artificial intelligence (AI) and deep learning (DL) techniques have shown promise in automating diagnostic tasks based on magnetic resonance imaging (MRI). This study evaluates the performance of four pre-trained deep convolutional neural network (CNN) architectures for the automatic multi-class classification of brain tumors into four categories: Glioma, Meningioma, Pituitary, and No Tumor. The proposed approach utilizes the publicly accessible Brain Tumor MRI Msoud dataset, consisting of 7023 images, with 5712 provided for training and 1311 for testing. To assess the impact of data availability, subsets containing 25%, 50%, 75%, and 100% of the training data were used. A stratified five-fold cross-validation technique was applied. The CNN architectures evaluated include DeiT3_base_patch16_224, Xception41, Inception_v4, and Swin_Tiny_Patch4_Window7_224, all fine-tuned using transfer learning. The training pipeline incorporated advanced preprocessing and image data augmentation techniques to enhance robustness and mitigate overfitting. Among the models tested, Swin_Tiny_Patch4_Window7_224 achieved the highest classification Accuracy of 99.24% on the test set using 75% of the training data. This model demonstrated superior generalization across all tumor classes and effectively addressed class imbalance issues. Furthermore, we deployed and benchmarked the best-performing DL model on embedded AI platforms (Jetson AGX Xavier and Orin Nano), demonstrating their capability for real-time inference and highlighting their feasibility for edge-based clinical deployment. The results highlight the strong potential of pre-trained deep CNN and transformer-based architectures in medical image analysis. The proposed approach provides a scalable and energy-efficient solution for automated brain tumor diagnosis, facilitating the integration of AI into clinical workflows.

The anatomical structure of the foot can be assessed by examining the plantar footprint for orthopedic intervention. In fact, there is a relationship between a specific type of foot and multiple musculoskeletal disorders, which are among the main ailments affecting the lower extremities, where its accurate classification is essential for early diagnosis. This work aims to develop a method for accurately classifying the plantar footprint and hindfoot, specifically concerning the sagittal plane. A custom image dataset was created, comprising 603 RGB plantar images that were modified and augmented. Six state-of-the-art models have been trained and evaluated: swin_tiny_patch4_window7_224, convnextv2_tiny, deit3_base_patch16_224, xception41, inception-v4, and efficientnet_b0. Among them, the swin_tiny_patch4_window7_224 model achieved 98.013% accuracy, demonstrating its potential as a reliable and low-cost tool for clinical screening and diagnosis of foot-related conditions.

Brain tumors, encompassing subtypes with distinct progression and risk profiles, are a serious public health concern. Magnetic resonance imaging (MRI) is the primary imaging modality for non-invasive assessment, providing the contrast and detail necessary for diagnosis, subtype classification, and individualized care planning. In this paper, we evaluate the capability of modern deep learning models to classify gliomas as high-grade (HGG) or low-grade (LGG) using reduced training data from MRI scans. Utilizing the BraTS 2019 best-slice dataset (2185 images in two classes, HGG and LGG) divided in two folders, training and testing, with different images obtained from different patients, we created subsets including 10%, 25%, 50%, 75%, and 100% of the dataset. Six deep learning architectures, DeiT3_base_patch16_224, Inception_v4, Xception41, ConvNextV2_tiny, swin_tiny_patch4_window7_224, and EfficientNet_B0, were evaluated utilizing three-fold cross-validation (k = 3) and increasingly large training datasets. Explainability was assessed using Grad-CAM. With 25% of the training data, DeiT3_base_patch16_224 achieved an accuracy of 99.401% and an F1-Score of 99.403%. Under the same conditions, Inception_v4 achieved an accuracy of 99.212% and a F1-Score of 99.222%. Considering how the models performed across both data subsets and their compute demands, Inception_v4 struck the best balance for MRI-based glioma classification. Both convolutional networks and vision transformers achieved superior discrimination between HGGs and LGGs, even under data-limited conditions. Architectural disparities became increasingly apparent as training data diminished, highlighting unique inductive biases and efficiency characteristics. Even with a relatively limited amount of training data, current deep learning (DL) methods can achieve reliable performance in classifying gliomas from MRI scans. Among the architectures evaluated, Inception_v4 offered the most consistent balance between accuracy, F1-Score, and computational cost, making it a strong candidate for integration into MRI-based clinical workflows.